Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Co |
| Molecular Weight | 58.933195 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Co]
InChI
InChIKey=GUTLYIVDDKVIGB-UHFFFAOYSA-N
InChI=1S/Co
| Molecular Formula | Co |
| Molecular Weight | 58.933195 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cobalt is a lustrous, silvery-blue magnetic metal. Cobalt is a bioessential element due to its location at the centre of vitamin B12. Vitamin B12 plays a number of vital roles in the physiology of the human body. Cobalt is also important in treatments of radiotherapy in the form of the isotope 60Co. Other medical uses of cobalt include the detection of tumours and metastases, sterilisation of surgical equipment and the imaging of damage to the brain. Cobalt is also used in the prosthetic alloys sector, being utilised in hip, knee and dental replacements. There are inorganic cobalt complexes that elicit biological effects with potential use as pharmaceutical agents. Three classes of cobalt complexes are present: 1) complexes that directly act on biomolecules through ligand exchange, 2) complexes that modify the activity of ligated drugs and 3) complexes that are activated by bioreduction to either (I) yield a cobalt effector species or (II) release a small molecule drug. Cobalt can cause a distinctive, rapidly progressive and reversible depression of cardiac systolic function, which is readily distinguished from other causes of cardiomyopathy.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comparative toxicity and carcinogenicity of soluble and insoluble cobalt compounds. | 2015-07-03 |
|
| Unusual Zn(II) Affinities of Zinc Fingers of Poly(ADP-ribose)Polymerase 1 (PARP-1) Nuclear Protein. | 2015-02-16 |
|
| BNIP3 upregulation by ERK and JNK mediates cadmium-induced necrosis in neuronal cells. | 2014-08-01 |
|
| Possible effects of metallosis on spermatozoal apoptotic genes expression in individuals with intramedullary nailing prosthesis. | 2014-06 |
|
| Genotoxic changes to rodent cells exposed in vitro to tungsten, nickel, cobalt and iron. | 2014-03-10 |
|
| Suppression of erythropoietin induction by diethylstilbestrol in rats. | 2014-01 |
|
| Cobalt and nickel stabilize stem cell transcription factor OCT4 through modulating its sumoylation and ubiquitination. | 2014 |
|
| Uptake, p53 pathway activation, and cytotoxic responses for Co(II) and Ni(II) in human lung cells: implications for carcinogenicity. | 2013-12 |
|
| Metal allergens induce nitric oxide production by mouse dermal fibroblasts via the hypoxia-inducible factor-2α-dependent pathway. | 2013-09 |
|
| Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis. | 2013-06-15 |
|
| Bioeffects of a combination of trace elements on adipocyte biology. | 2013-05 |
|
| Hard-metal (WC-Co) particles trigger a signaling cascade involving p38 MAPK, HIF-1α, HMOX1, and p53 activation in human PBMC. | 2013-02 |
|
| Induction of miR-21-PDCD4 signaling by tungsten carbide-cobalt nanoparticles in JB6 cells involves ROS-mediated MAPK pathways. | 2013 |
|
| Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis. | 2013 |
|
| The effects of cobalt on the development, oxidative stress, and apoptosis in zebrafish embryos. | 2012-12 |
|
| In vivo corrosion, tumor outcome, and microarray gene expression for two types of muscle-implanted tungsten alloys. | 2012-11-15 |
|
| ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. | 2012-10-05 |
|
| Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1. | 2012-08-31 |
|
| Allosteric inhibition of cobalt binding to albumin by fatty acids: implications for the detection of myocardial ischemia. | 2012-05-10 |
|
| A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity. | 2012-04-21 |
|
| Effects of cobalt nanoparticles on human T cells in vitro. | 2012-04 |
|
| The iron transporter ferroportin can also function as a manganese exporter. | 2012-03 |
|
| Goldfish exposure to cobalt enhances hemoglobin level and triggers tissue-specific elevation of antioxidant defenses in gills, heart and spleen. | 2012-03 |
|
| Pulmonary toxicity after exposure to military-relevant heavy metal tungsten alloy particles. | 2012-02-15 |
|
| Cobalt(II) β-ketoaminato complexes as novel inhibitors of neuroinflammation. | 2012-02-15 |
|
| Biological evaluation of cobalt(II) complexes with non-steroidal anti-inflammatory drug naproxen. | 2012-02 |
|
| Gene expression profiles for genotoxic effects of silica-free and silica-coated cobalt ferrite nanoparticles. | 2012-01 |
|
| Cobalt-induced oxidative stress in brain, liver and kidney of goldfish Carassius auratus. | 2011-10 |
|
| Cytotoxic property of surfactant-cobalt(III) complexes on a human breast cancer cell line. | 2011-07 |
|
| The synthesis and characterization of a series of cobalt(II) β-ketoaminato complexes and their cytotoxic activity towards human tumor cell lines. | 2011-06 |
|
| Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes. | 2011-02 |
|
| Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition. | 2011-02 |
|
| Reactive oxygen species and oxidative DNA damage mediate the cytotoxicity of tungsten-nickel-cobalt alloys in vitro. | 2011-01-01 |
|
| Purification and characterization of porcine skeletal muscle aminopeptidase T, a novel metallopeptidase homologous to leukotriene A4 hydrolase. | 2011 |
|
| NRF2 Oxidative Stress Induced by Heavy Metals is Cell Type Dependent. | 2011 |
|
| The monitoring of trace elements in blood samples from patients with inborn errors of metabolism. | 2010-12 |
|
| Enhanced photodynamic effect of cobalt(III) dipyridophenazine complex on thyrotropin receptor expressing HEK293 cells. | 2010-11 |
|
| Tungsten carbide cobalt nanoparticles exert hypoxia-like effects on the gene expression level in human keratinocytes. | 2010-01-27 |
|
| Tungsten carbide-cobalt particles activate Nrf2 and its downstream target genes in JB6 cells possibly by ROS generation. | 2010 |
|
| Size-dependent effects of tungsten carbide-cobalt particles on oxygen radical production and activation of cell signaling pathways in murine epidermal cells. | 2009-12-15 |
|
| Cobalt ions induce chemokine secretion in primary human osteoblasts. | 2009-07 |
|
| Effects of various metal ions on the gene expression of iron exporter ferroportin-1 in J774 macrophages. | 2008 |
|
| Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin. | 1990-12-01 |
|
| Aryl hydrocarbon (Ah) receptor DNA-binding activity. Sequence specificity and Zn2+ requirement. | 1990-06-05 |
|
| [Calcium influx: an intracellular message of the mitogenic action of insulin-like growth factors]. | 1989-03 |
|
| Calcium influx: an intracellular message of the mitogenic action of insulin-like growth factor-I. | 1988-11-15 |
|
| Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. | 1988-09-01 |
|
| Evidence suggesting that the two forms of heme oxygenase are products of different genes. | 1988-03-05 |
|
| Insulin-like growth factor II stimulates calcium influx in competent BALB/c 3T3 cells primed with epidermal growth factor. Characteristics of calcium influx and involvement of GTP-binding protein. | 1987-09-05 |
|
| Human and canine ventricular vasoactive intestinal polypeptide: decrease with heart failure. | 1986-07 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:24:22 GMT 2025
by
admin
on
Mon Mar 31 18:24:22 GMT 2025
|
| Record UNII |
3G0H8C9362
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
42 (Number of products:65)
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
||
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
||
|
CFR |
21 CFR 216.24
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
||
|
NCI_THESAURUS |
C896
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1310300
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | RxNorm | ||
|
Cobalt
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
104730
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
34631
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
DB14574
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
C382
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
SUB13406MIG
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
3G0H8C9362
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
DTXSID1031040
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
7440-48-4
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
D003035
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
N0000175629
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] | ||
|
N0000184306
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
231-158-0
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
519
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
3G0H8C9362
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
100000076274
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | |||
|
m3681
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY | Merck Index | ||
|
27638
Created by
admin on Mon Mar 31 18:24:22 GMT 2025 , Edited by admin on Mon Mar 31 18:24:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |